This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Medimmune Limited. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2022
Title: Innovations by Balaji Agoram in Obesity Treatment
Introduction
Balaji Agoram is an accomplished inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of metabolic disease treatment, particularly focusing on obesity. With a total of 3 patents to his name, Agoram's work is paving the way for innovative therapeutic solutions.
Latest Patents
Among his latest patents, Agoram has developed glucagon/GLP-1 agonists for the treatment of obesity. This disclosure provides GLP-1/glucagon agonist peptides aimed at addressing metabolic diseases, such as obesity. His research in this area is crucial for advancing treatment options for individuals struggling with weight management.
Career Highlights
Agoram is currently employed at MedImmune Limited, where he continues to push the boundaries of scientific research and innovation. His work at this prominent company allows him to collaborate with other experts in the field, enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Madeleine Antonsson and Maria Aleksandra Bednarek. Their collective expertise contributes to the success of the projects they undertake together.
Conclusion
Balaji Agoram's innovative work in developing glucagon/GLP-1 agonists represents a significant advancement in the treatment of obesity. His contributions are vital for the future of metabolic disease therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile